These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26025496)

  • 1. Do circulating tumor cells have a role in deciding on adjuvant chemotherapy after radical cystectomy?
    Soave A; Riethdorf S; Pantel K; Fisch M; Rink M
    Curr Urol Rep; 2015 Jul; 16(7):46. PubMed ID: 26025496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study.
    Rink M; Chun FK; Dahlem R; Soave A; Minner S; Hansen J; Stoupiec M; Coith C; Kluth LA; Ahyai SA; Friedrich MG; Shariat SF; Fisch M; Pantel K; Riethdorf S
    Eur Urol; 2012 Apr; 61(4):810-7. PubMed ID: 22277196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapy.
    Soave A; Riethdorf S; Dahlem R; von Amsberg G; Minner S; Weisbach L; Engel O; Fisch M; Pantel K; Rink M
    Int J Cancer; 2017 Jan; 140(2):381-389. PubMed ID: 27668704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy.
    Soave A; Riethdorf S; Dahlem R; Minner S; Weisbach L; Engel O; Fisch M; Pantel K; Rink M
    BJU Int; 2017 Jun; 119(6):854-861. PubMed ID: 28182321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary on "Detection and oncological effect of circulating tumor cells in patients with variant urothelial carcinoma histology treated with radical cystectomy.".
    Soave A; Riethdorf S; Dahlem R; Minner S; Weisbach L; Engel O; Fisch M; Pantel K; Rink M
    Urol Oncol; 2018 Jul; 36(7):347-348. PubMed ID: 29880457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy.
    Rink M; Hansen J; Cha EK; Green DA; Babjuk M; Svatek RS; Xylinas E; Tagawa ST; Faison T; Novara G; Karakiewicz PI; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Pycha A; Comploj E; Tilki D; Bastian PJ; Chun FK; Dahlem R; Scherr DS; Shariat SF
    BJU Int; 2013 Jan; 111(1):74-84. PubMed ID: 22809039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients.
    Lucca I; Rouprêt M; Kluth L; Rink M; Tilki D; Fajkovic H; Kassouf W; Hofbauer SL; de Martino M; Karakiewicz PI; Briganti A; Trinh QD; Seitz C; Fritsche HM; Burger M; Lotan Y; Kramer G; Shariat SF; Klatte T
    BJU Int; 2015 May; 115(5):722-7. PubMed ID: 24905084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender-specific outcomes of bladder cancer patients: a stage-specific analysis in a contemporary, homogenous radical cystectomy cohort.
    Soave A; Dahlem R; Hansen J; Weisbach L; Minner S; Engel O; Kluth LA; Chun FK; Shariat SF; Fisch M; Rink M
    Eur J Surg Oncol; 2015 Mar; 41(3):368-77. PubMed ID: 24674298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery.
    Rink M; Ehdaie B; Cha EK; Green DA; Karakiewicz PI; Babjuk M; Margulis V; Raman JD; Svatek RS; Fajkovic H; Lee RK; Novara G; Hansen J; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Pycha A; Fisch M; Scherr DS; Shariat SF; ;
    Eur Urol; 2012 Oct; 62(4):677-84. PubMed ID: 22349570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current role and future directions of circulating tumor cells and circulating tumor DNA in urothelial carcinoma of the bladder.
    Rink M; Schwarzenbach H; Riethdorf S; Soave A
    World J Urol; 2019 Sep; 37(9):1785-1799. PubMed ID: 30367205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence of circulating tumor cells does not predict extravesical disease in bladder cancer patients prior to radical cystectomy.
    Guzzo TJ; McNeil BK; Bivalacqua TJ; Elliott DJ; Sokoll LJ; Schoenberg MP
    Urol Oncol; 2012; 30(1):44-8. PubMed ID: 20005748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy.
    Shariat SF; Rink M; Ehdaie B; Xylinas E; Babjuk M; Merseburger AS; Svatek RS; Cha EK; Tagawa ST; Fajkovic H; Novara G; Karakiewicz PI; Trinh QD; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Chun FK; Sonpavde G; Joual A; Scherr DS; Gonen M
    Eur Urol; 2013 Feb; 63(2):371-8. PubMed ID: 22727174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of SPINK1 expression is associated with unfavorable outcomes in urothelial carcinoma of the bladder after radical cystectomy.
    Rink M; Park K; Volkmer BG; Xylinas E; Hansen J; Cha EK; Robinson BD; Hautmann R; Küfer R; Engel O; Chun FK; Dahlem R; Rubin MA; Shariat SF; Mosquera JM
    Urol Oncol; 2013 Nov; 31(8):1716-24. PubMed ID: 22944196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
    Stein JP; Cai J; Groshen S; Skinner DG
    J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort.
    Fritsche HM; Burger M; Svatek RS; Jeldres C; Karakiewicz PI; Novara G; Skinner E; Denzinger S; Fradet Y; Isbarn H; Bastian PJ; Volkmer BG; Montorsi F; Kassouf W; Tilki D; Otto W; Capitanio U; Izawa JI; Ficarra V; Lerner S; Sagalowsky AI; Schoenberg M; Kamat A; Dinney CP; Lotan Y; Shariat SF
    Eur Urol; 2010 Feb; 57(2):300-9. PubMed ID: 19766384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
    Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF
    Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accurate preoperative prediction of non-organ-confined bladder urothelial carcinoma at cystectomy.
    Green DA; Rink M; Hansen J; Cha EK; Robinson B; Tian Z; Chun FK; Tagawa S; Karakiewicz PI; Fisch M; Scherr DS; Shariat SF
    BJU Int; 2013 Mar; 111(3):404-11. PubMed ID: 22805163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
    Xylinas E; Rink M; Robinson BD; Lotan Y; Babjuk M; Brisuda A; Green DA; Kluth LA; Pycha A; Fradet Y; Faison T; Lee RK; Karakiewicz PI; Zerbib M; Scherr DS; Shariat SF
    Eur J Cancer; 2013 May; 49(8):1889-97. PubMed ID: 23466126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy.
    Shariat SF; Svatek RS; Tilki D; Skinner E; Karakiewicz PI; Capitanio U; Bastian PJ; Volkmer BG; Kassouf W; Novara G; Fritsche HM; Izawa JI; Ficarra V; Lerner SP; Sagalowsky AI; Schoenberg MP; Kamat AM; Dinney CP; Lotan Y; Marberger MJ; Fradet Y
    BJU Int; 2010 May; 105(10):1402-12. PubMed ID: 20132195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy.
    Rink M; Zabor EC; Furberg H; Xylinas E; Ehdaie B; Novara G; Babjuk M; Pycha A; Lotan Y; Trinh QD; Chun FK; Lee RK; Karakiewicz PI; Fisch M; Robinson BD; Scherr DS; Shariat SF
    Eur Urol; 2013 Sep; 64(3):456-64. PubMed ID: 23206854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.